ADAMTS8 and colorectal carcinoma: Overexpression of ADAMTS8 was shown to reduce β-catenin levels, as well as the phosphorylation of GSK3β, leading to reduced CRC cell invasion and migration in vitro and reduced tumour growth in vivo (Fig. 5B)[23].